PhuturdexDrug Pipeline Intelligence

Phuturdex › Diseases › Chickenpox

Drugs in development · updated 30 October 2026

Chickenpox: drugs in development

As of 30 October 2026 there are 17 active clinical trials (recruiting or ongoing, phases I–III) on 13 drugs for chickenpox. 8 are experimental, that is not yet approved in the United States.

17Active trials
8Experimental drugs
5Experimental, in phase III

Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.

Sign in free →

Experimental drugs

Not yet approved by the US FDA for any indication.

DrugMost advanced phaseActive trialsReference trial
PCV 13III4NCT06806137
PCV20III4NCT06806137
ABO1108III3NCT07817108
MG1111III2NCT07054099
NBP608III1NCT07415252
CVI-VZV-001II1NCT07481604
SuduvaxII1NCT05422508
LYB004I1NCT06335849

Sorted by most advanced phase and number of active trials.

Approved drugs in new trials

Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.

DrugMost advanced phaseActive trialsReference trial
VaxneuvanceIII4NCT06806137
VarivaxIII3NCT07415252
ShingrixII7NCT07481604
CyclophosphamideCyclophosphamid, CytoxanI1NCT01953900
FludarabineFludara, FLUDARABINI1NCT01953900

Sorted by most advanced phase and number of active trials.

All 13 drugs, with the details

In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.

Open in Phuturdex →

Broader categories

Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D002644 “Chickenpox”.

ItalianoFrançaisDeutsch